The Photoprotective Effect of S-Methylmethionine Sulfonium in Skin

    July 2015 in “ International Journal of Molecular Sciences ”
    Won-Serk Kim, Hyun‐Min Seo, Wang-Kyun Kim, Joon-Seok Choi, Ikyon Kim, Jong-Hyuk Sung
    TLDR S-Methylmethionine sulfonium can protect skin from UVB damage.
    The study investigated the photoprotective effects of S-Methylmethionine sulfonium (SMMS) on skin cells and hairless rats exposed to UVB radiation. In vitro, SMMS increased the viability of keratinocyte progenitor cells (KPCs) and human dermal fibroblasts (hDFs) by reducing UVB-induced apoptosis and reactive oxygen species (ROS) generation, and by modulating the MAPK/ERK signaling pathway. In vivo, topical application of SMMS on hairless albino rats significantly reduced UVB-induced skin erythema and depletion of epidermal Langerhans cells. These findings suggested that SMMS could serve as a potential photoprotective agent against UVB-induced skin damage.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community What's your thoughts on Pyrilutamide

      in Product  5 upvotes 3 days ago
      The conversation is about using pyrilutamide and RU58841 as topical solutions to prevent hair loss. Pyrilutamide is considered safer but less potent than RU58841, which some users find effective despite potential side effects like heart palpitations.
      That’s it i’m starting oral Minoxidil

      community That’s it i’m starting oral Minoxidil

      in General  134 upvotes 1 week ago
      A 32-year-old man started oral minoxidil at 0.625mg daily, alongside topical minoxidil, to address hair thinning after experiencing side effects from other treatments. He plans to monitor his health closely and adjust the dosage after two months.

      community What’s your views on clascoterone 5% topical solution by cosmo

      in Research/Science  21 upvotes 1 week ago
      Clascoterone 5% topical solution shows promise for treating male-pattern hair loss by blocking DHT at the follicle without systemic absorption, potentially offering fewer side effects than oral treatments like finasteride. While results are promising, long-term safety and effectiveness need further study, and it may serve as a starting point for developing more effective treatments.

      community What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news

      in Chat  12 upvotes 1 week ago
      Hmi115, a prolactin receptor blocker, showed promise for hair growth, but results from Phase 2 trials have not been published. ABS-201, an AI-based analog, is expected to begin trials in December 2025, while commercialization of treatments like PP-405 is anticipated around 2027.
      What’s the best course of action for me? M27

      community What’s the best course of action for me? M27

      in General  123 upvotes 2 weeks ago
      The user is concerned about hair loss and is hesitant to use treatments like finasteride and minoxidil due to potential side effects. Another user suggests gradually introducing finasteride to minimize side effects and maximize results.

      community It's so over. Im beyond cooked

      in Update 1 month ago
      The user is experiencing hair loss despite using Dutasteride and plans to try RU58841, considering adding Oral Minoxidil. They express frustration with diffuse thinning and seek advice on managing hair loss.

    Similar Research

    5 / 1000+ results